跳至主要内容
临床试验/IRCT201202041556N32
IRCT201202041556N32已完成2 期

Granisetron in the treatment of obsessive-compulsive disorder: a double-blind, placebo controlled trial

Tehran University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 60 years(—)
性别
All

入选标准

  • Inclusion Criteria:Age between 18-60; Diagnosis of OCD based on DSM IV; Minimum Score of 21 on YALE-BROWN Obsessive-Compulsive Scale

排除标准

  • Substance dependence; IQ <70; any other mental disorder on axis I; Any serious cardiac, renal or hepatic disease ; receiving psychotropic medications during the last 6 weeks ; pregnancy orbreast feeding; rising liver transaminases to three times the upper limit of normal or higher

研究者

相似试验